Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease

Maier-Redelsperger, Micheline; de Montalembert, M.; Flahault, Antoine; Neonato, Maria Grazia; Ducrocq, R.; Masson, M. P.; Girot, Robert; Elion, J.

Scientific article

English

Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease

ContributorsMaier-Redelsperger, Micheline; de Montalembert, M.; Flahault, Antoine; Neonato, Maria Grazia; Ducrocq, R.; Masson, M. P.; Girot, Robert; Elion, J.

Published inBlood, vol. 91, no. 12, p. 4472-4479

Publication date1998

Keywords

Adolescent
Adult
Anemia, Sickle Cell/*blood/*drug therapy/*pathology
Antisickling Agents/*administration & dosage
Child
Child, Preschool
Female
Fetal Hemoglobin/*metabolism
Follow-Up Studies
Humans
Hydroxyurea/*administration & dosage
Male
Reticulocytes/*metabolism
Time Factors

Affiliation entities

Not a UNIGE publication

Citation (ISO format)

MAIER-REDELSPERGER, Micheline et al. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease. In: Blood, 1998, vol. 91, n° 12, p. 4472–4479.

Article (Published version)

Identifiers

PID : unige:47023
PMID : 9616141

Journal ISSN0006-4971

572views

338downloads

Creation02/23/2015 2:34:43 PM

First validation02/23/2015 2:34:43 PM

Update time03/14/2023 10:52:40 PM

Status update03/14/2023 10:52:40 PM

Last indexation10/30/2024 11:00:57 PM

Archive ouverte UNIGE

Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease

Technical informations